Login / Signup

Enhanced recovery after surgery strategy for cirrhosis patients undergoing hepatectomy: experience in a single research center.

Yiling ZhengLi-Ming WangFan WuWeiqi RongYunhe LiuKai ZhangJianxiong Wu
Published in: Annals of surgical treatment and research (2020)
The ERAS programme is safe and effective for HCC patients with chronic liver disease undergoing hepatectomy, but it seems that surgical factors, such as operation type, have a greater impact on morbidity than other factors. Operative characteristics such as the method of blood loss control and the volume of liver resection should be augmented into ERAS protocol of hepatectomy.
Keyphrases
  • patients undergoing
  • liver metastases
  • randomized controlled trial
  • study protocol
  • clinical trial